HLS Therapeutics Inc's total assets for Q3 2025 were $140.23M, a decrease of -5.93% from the previous quarter. TSE:HLS total liabilities were $78.49M for the fiscal quarter, a -4.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.